RBLX bets big on its developer community as creator payouts surge and new tools drive record earnings momentum.

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased the securities of Fiserv, Inc. (“Fiserv” or the “Company”) (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”).

CFRA's Angelo Zino points to two key issues with Intel (INTC) after earnings: pressured margins despite cost-cutting measures, and a "blurry" strategic direction. He believes the company needs to put critical emphasis on its foundry and software businesses to stop to bleeding.

Healthpeak Properties, Inc. (NYSE:DOC ) Q2 2025 Earnings Conference Call July 25, 2025 10:00 AM ET Company Participants Andrew Johns - Senior Vice President of Investor Relations Kelvin O. Moses - Chief Financial Officer Mark Theine - Corporate Participant Scott M.

Momentum investors have a lot to dig through after an explosive tech-led surge from those now-distant Liberation Day lows.

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.

ITGR posts strong second-quarter revenue growth, but EPS misses estimate despite solid segment momentum.

BFH tops Q2 EPS estimates by nearly 70% as credit sales rise, even as revenues dip on lower finance charges and late fees.

The Investment Committee give you their top stocks to watch for the second half.

The aggressive expansion for Palazzo signals confidence in Asian gaming markets. Non-stop growth in Asia highlights strong demand for integrated resorts and entertainment. Strategic investments position the company to capture emerging opportunities in the region.

Cytokinetics continues to near unaminous positive analyst sentiment, with most price targets well above current levels, reflecting strong growth expectations. The company's NDA around its lead drug candidate was delayed by three months recently. However, Cytokinetics maintains a robust cash position of $1.1 billion, supporting ongoing operations and R&D. If all goes according to schedule, Cytokinetics should receive the first of many FDA approvals late this year and has several potential catalysts on the horizon.

The company ended its second quarter with $797.5 million in cash and extended its cash runway into 2029.

ServiceNow's NYSE: NOW Q2 results and guidance update are a wow moment for investors and an eye-opener for those waiting on AI's second wave. The second wave, the rise of agentic services and the application of AI, is expected to be a larger, faster-growing, and longer-sustained rally than infrastructure, which has been a rocket-ship of gains for technology investors.

VRT benefits from AI-driven demand with strong Q2 growth expected, but stretched valuation may give investors pause ahead of earnings.

RGTI jumps 44% in a month after hitting a major quantum milestone, as investors eye its chiplet-based 100+ qubit roadmap.

Western New England Bancorp (WNEB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

NB Bancorp, Inc. (NBBK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Synovus Financial (SNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Hagerty, Inc. (HGTY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The Investment Committee debate the latest Calls of the Day.